About Lyell McEwin Hospital
The Lyell McEwin Hospital is a major tertiary hospital located in Adelaide, South Australia that provides medical, surgical, diagnostic, emergency and support services to a population of more than 300,000 people living primarily in Adelaide's north and north eastern suburbs.
Clinical Trials at Lyell McEwin Hospital
During the past decade, Lyell McEwin Hospital conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 12 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 7 clinical trials were completed. i.e. 41.2%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Lyell McEwin Hospital" #1 sponsor was "BeiGene" with 3 trials, followed by "Neuroscience Trials Australia" with 3 trials
sponsored, "Pfizer" with 3 trials sponsored, "Australasian Gastro-Intestinal Trials Group" with 2 trials sponsored and "Boehringer Ingelheim"
with 2 trials sponsored. Other sponsors include 35 different institutions and
companies that sponsored additional 37 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Lyell McEwin Hospital"
#1 collaborator was "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 4 trials as a collaborator, "The Florey Institute of Neuroscience and Mental Health" with 3 trials as a collaborator, "Eisai Inc." with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator and "National Health and Medical Research Council, Australia" with 2 trials as a collaborator. Other collaborators include 40 different institutions and companies that were
collaborators in the rest 50 trials.
Clinical Trials Conditions at Lyell McEwin Hospital
According to Clinical.Site data, the most researched conditions in "Lyell McEwin Hospital" are
"Eosinophilic Esophagitis" (4 trials), "Heart Failure" (3 trials), "Ischemic Stroke" (3 trials), "Breast Cancer" (2 trials) and "Carcinoma, Renal Cell" (2 trials). Many other conditions were trialed in "Lyell McEwin Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Lyell McEwin Hospital
Most popular intervention types in "Lyell McEwin Hospital" are "Drug" (41 trials), "Other" (13 trials), "Biological" (6 trials), "Device" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (16 trials), "Docetaxel" (3 trials), "Paclitaxel" (3 trials), "Tislelizumab" (3 trials) and "Abemaciclib" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Lyell McEwin Hospital
The vast majority of trials in "Lyell McEwin Hospital" are
52 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Lyell McEwin Hospital
Currently, there are NaN active trials in "Lyell McEwin Hospital".
undefined are not yet recruiting,
16 are recruiting,
8 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 20 completed trials in Lyell McEwin Hospital,
undefined suspended trials,
and 7 terminated clinical trials to date.
Out of the total trials that were conducted in Lyell McEwin Hospital, 1 "Phase 1"
clinical trials were conducted, 13 "Phase 2" clinical
trials and 30 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 9 trials that are defined as “Not Applicable".
Departments of Lyell McEwin Hospital
Lyell McEwin Hospital has several departments that took part in Clinical trials: "Queen Elizabeth Hospital; Haematology" - 9 trials, "The Queen Elizabeth Hospital; Neurology" - 7 trials, "Flinders Medical Centre, Dept. of Oncology" - 7 trials, "Department of Medical Oncology" - 2 trials, "South Australian Spinal Cord Injury Service, Hampstead Rehabilitation Centre" - 2 trials, "Southern Adelaide Diabetes and Endocrine Service" - 2 trials, "Lyell McEwin Hospital; Oncology Clinical Trials, Chemotherapy Day Unit" - 2 trials